B.O.S.S. Retirement Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-4,142
Closed -$213K – 139
2023
Q4
$213K Sell
4,142
-223
-5% -$11.7K 0.04% 234
2023
Q3
$253K Buy
4,365
+589
+16% +$36.1K 0.05% 215
2023
Q2
$241K Sell
3,776
-18,142
-83% -$1.22M 0.05% 220
2023
Q1
$1.52M Buy
21,918
+138
+0.6% +$9.73K 0.36% 117
2022
Q4
$1.57M Buy
+21,780
New +$1.64M 0.4% 107

Other funds holding BMY

B.O.S.S. Retirement Advisors's BMY Position: Q1 2024 in Review

B.O.S.S. Retirement Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,142 shares — an estimated $213K sold.

B.O.S.S. Retirement Advisors first reported a position in BMY in Q4 2022 and held it in 5 quarters. The position peaked at $1.57M in Q4 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • B.O.S.S. Retirement Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • B.O.S.S. Retirement Advisors sold 4,142 Bristol-Myers Squibb shares in Q1 2024, an estimated $213K.
  • B.O.S.S. Retirement Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 5 quarters.
  • B.O.S.S. Retirement Advisors's Bristol-Myers Squibb position peaked at $1.57M in Q4 2022.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.